RT Journal Article
SR Electronic
T1 COVID-19 and Immunomodulatory Therapy — Can We Use Data from Previous Viral Pandemics?
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP jrheum.200527
DO 10.3899/jrheum.200527
A1 Hannah Jethwa
A1 Ann Sullivan
A1 Sonya Abraham
YR 2020
UL http://www.jrheum.org/content/early/2020/06/25/jrheum.200527.abstract
AB The implications of COVID-19 are wide-ranging for specialties such as rheumatology in which immunomodulatory therapies are prescribed. There has been much trepidation among many healthcare professionals regarding the best course of management during this time.